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ABSTRACT
Objective: To evaluate the effect of oral appliance (OA) treatment on upper-airway ventilation
conditions in patients with obstructive sleep apnea (OSA) using computational fluid dynamics
(CFD).
Methods: Fifteen patients received OA treatment and underwent polysomnography (PSG) and
computed tomography (CT). CT data were used to reconstruct three-dimensional models of nasal
and pharyngeal airways. Airflow velocity and airway pressure measurements at inspiration were
simulated using CFD.
Results: The apnea–hypopnea index (AHI) improved from 23.1 to 10.1 events/h after OA treat-
ment. On CFD analysis, airflow velocity decreased at the retropalatal and epiglottis-tip levels,
while airway pressure decreased at the retropalatal, uvular- and epiglottis-tip levels. The AHI of
patients with OSA before OA treatment was correlated with airway pressure at the epiglottis-tip
level.
Discussion: Treatment with OA improved the ventilation conditions of the pharyngeal airway and
AHI. Results of CFD analysis of airway pressure and airflow velocity helped determine the severity










Obstructive sleep apnea (OSA) is an obstructive
respiratory disorder that occurs repeatedly during
sleep. Consequently, sleep is fragmented, which results
in the shortage of sleep; thus, patients experience som-
nolence during the day, leading to a decrease in activ-
ity. Moreover, when left untreated, OSA can cause
long-term complications, such as cardiac, circulatory,
and endocrine diseases, and mental illness. Several
adverse effects of OSA on vital prognosis have been
reported [1–3].
Currently, mainstream therapies for OSA include
weight loss for obese patients and conservative treat-
ment using continuous positive airway pressure
(CPAP) and oral appliances (OAs) [4–6]. Although
CPAP treatment is the gold standard, there are cases
in which the CPAP apparatus cannot be employed due
to issues with its operability or portability or a sense of
continuous incongruity with the mask [7].
Guidelines issued by the American Academy of
Sleep Medicine (AASM) state that OA treatment is
indicated in patients with mild-to-moderate OSA and
in those for whom CPAP is not indicated [8]. However,
severe OSA has been shown to respond to OA treat-
ment. Johal et al. [9] reported that six of eight subjects
with severe OSA were successfully treated with OA
treatment. Therefore, the indication for OA treatment
cannot be determined solely on the basis of OSA
severity. To determine whether OA treatment is indi-
cated for a patient, it is necessary to evaluate and
consider not only the apnea–hypopnea index (AHI)
but also upper-airway ventilation conditions.
Previously, cephalometry [10], computed tomography
(CT) [11], and endoscopy [12] were used for the evaluation
of upper-airway ventilation conditions during OA treat-
ment. However, because the upper airway is complicated
and extends from the nose to the hypopharynx, the positive
effects ofOA treatment on ventilation conditions cannot be
determined solely by morphologic observation. Recent
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OSA–airflow studies have employed computational fluid
dynamics (CFD) for analysis [13–17]. In two of those
studies, the pharyngeal airway ventilation conditions were
changed by use of rapid maxillary expansion and Herbst
appliance using CFD [15,16]. Additionally, Mihaescu et al.
[14] evaluated changes in the ventilation conditions of the
upper airway by maxillomandibular advancement surgery
using CFD. The authors of the present study believe that
CFD is very effective for the evaluation of upper-airway
ventilation conditions, as it can evaluate the flow of air in
a manner similar to that during actual breathing, even in
cases of upper airways with complicated morphologies.
The large negative pressure measured in the pharyngeal
airway by CFD may predict pharyngeal-airway collapse
during sleep [18,19].
Moreover, functional evaluation of the upper airway
using CFD might provide new findings that are not
available from morphologic evaluation alone.
This retrospective study was conducted for the pur-
pose of evaluating the effect of OA treatment on upper-
airway ventilation conditions in OSA using CFD.
Materials and methods
Subjects
This retrospective study included 15 patients (13men and
2 women) with OSA who first visited Yamaguchi
University Hospital in Ube, Japan between June 2009
and March 2012. The mean age and body mass index
(BMI) of the study group were 51.3 years and 23.9 kg/m2,
respectively (Table 1). The mean AHI, apnea index (AI),
hypopnea index (HI), and lowest oxygen saturation level
(SpO2) were 23.1 events/h, 10.5 events/h, 12.6 events/h,
and 82.1%, respectively. Those with mild to moderate
OSA, determined by polysomnographic (PSG) examina-
tions, received OA treatment. In addition, those with
severe OSA who dropped out of CPAP treatment
received OA treatment [8]. Patients were administered
OA treatment with one of two types of mandibular-
repositioning devices: seven patients with a history of
temporomandibular disorder (TMD) symptoms, such as
clicks, received duoblock-type OAs [20–22], while eight
patients without the TMD symptoms received mono-
block-type OAs [21,23,24]. For both OA types, the man-
dibular protruded positions were titrated. Initially,
mandible advancement was set at 50% of the maximum
mandibular protruded position. OAs were incrementally
titrated according to either a maximal comfortable pro-
truded position of the mandible or a resolution of snoring
and daytime symptoms [25]. Isacsson et al. [26] reported
that there was no significant difference in the treatment
effects between the duoblock-type and monoblock-type
devices. In this study, there was no significant difference
in the amount of mandibular advancement set with either
device (monoblock vs. duoblock). Additionally, there was
no significant difference in the PSG data (AHI, AI, HI, or
SpO2) measured before and after the treatment.
Therefore, the present study analyzed the data of the
monoblock and duoblock OA groups together.
This study was performed under the approval of
Kagoshima University (Kagoshima, Japan; No. 180073
(657) Epi-ver.1) and Yamaguchi University (Yamaguchi,
Japan; No. H28-138). Because of the retrospective nature
of this study, the requirement for informed consent was
waived, and an exemption was granted in writing by the
institutional review board.
Polysomnographic and CT examinations
All patients underwent PSG (Alice 5 Diagnostic Sleep
System, Philips Respironics, Best, The Netherlands) and
CT during the initial consultation and after confirming
that there was no problem with the use of OAs after the
titration. After the symptom improvement PSG and CT
examinations were performed at a mean of six months
following the start of OA treatment, with the OA in place.
The AHI, AI, HI, and lowest SpO2 level were measured by
PSG. Apnea was defined as complete cessation of airflow
for 10 s, and hypopnea was defined as a 50% reduction in
oronasal airflow lasting 10 s with at least 3% desaturation.
The AHI was calculated as the number of apnea and
hypopnea events per hour of sleep [8].
During the CT examination, each patient was asked
not to move his or her head or swallow at the end of
expiration. Multi-slice helical CT (SOMATOM
Definition, Siemens AG, Erlangen, Germany) images
of the upper airway were acquired in supine position in
order to reproduce sleep-related breathing conditions.
The slice thickness was 0.6 mm. Imaging data were
transferred directly to a personal computer and stored
in the Digital Imaging and Communications in
Medicine format. Before the CT exam, the patients
were fully informed of the purpose and risks of the
procedure.
Table 1. Baseline characteristics of patients in the study group.
Variable Mean SD Range
Age, years 51.3 12.8 28–76
BMI, kg/m2 23.9 3.0 20.2–30.7
AHI, events/h 23.1 12.0 7.2–50.3
AI, events/h 10.5 12.0 0.4–40.0
HI, events/h 12.6 6.7 2.5–28.7
Lowest SpO2, %
# 82.1 7.9 67–93
SD: standard deviation; BMI: body mass index; AHI: apnea–hypopnea index;
AI: apnea index; HI: hypopnea index; SpO2: oxygen saturation.
#It was not possible to measure the SpO2 level in one case.
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Evaluation of upper airway ventilation conditions
Three-dimensional (3D) reconstructions of the upper air-
way were generated from the CT data using
volume-rendering software (Intage Volume Editor;
Cybernet, Tokyo, Japan). The airway was segmented pri-
marily on the basis of image intensity with the threshold
set midway between the soft tissue and clear airway value.
As a result, the threshold was shown from −550 to 1024
Hounsfield Units [27]. Subsequently, the 3D models were
converted into smoothed models using mesh-morphing
software (DEP Mesh Works/Morpher; IDAJ Co., Kobe,
Japan), without losing the patient-specific shape of the
upper airway. The ventilation conditions of these upper-
airway models were then evaluated by CFD. The models
were exported to a fluid-dynamics program (Phoenics;
CHAM-Japan, Tokyo, Japan) in stereolithographic format.
The fluid was assumed to be Newtonian, homogeneous,
and incompressible. Elliptic-staggered equations and the
continuity equation were used for analysis. The CFD of the
upper-airway models were analyzed at a volumetric flow
rate of 500 cm3/s and a no-slip condition at the wall surface
[28]. Mean values were calculated after 500 iterations.
Convergence was judged bymonitoring themagnitudes
of absolute residual sources of mass and momentum nor-
malized to their respective inlet fluxes. Iteration was con-
tinued until all residuals fell below 0.2% [15,16]. The
simulation estimated the airway pressure and airflow velo-
city at the hard-palate, retropalatal, uvular-tip, and epiglot-
tis-tip levels (Figure 1).
Statistical analysis
In this study, no significant differences in variables were
found in relation to sex and age. Therefore, statistical
analysis was performed using a pooled sample. For all
variables, the paired t-test was performed to determine
the significance of the treatment-associated changes
detected after PSG. Whenever a variable exhibited non-
normal distribution of data or differing variance, the sig-
nificance of treatment-associated changes after CFD was
determined using the nonparametric Wilcoxon rank test.
Intersite differences were determined using the Friedman
test with Bonferroni correction. Spearman’s correlation
coefficients were calculated to evaluate the relationships
between PSG data and maximal negative pressure within
the four parts of the pharyngeal airway. Statistical signifi-
cance in all tests was set at p < 0.05.
A power analysis was performed to calculate the
β error (1 – β error = 0.80; α = 0.05; two-tailed
test); the target sample size was 13 subjects.
Therefore, the present sample size was sufficient
for this analysis. All measurements were repeated
after one week by the same investigator (HS), and
method errors were calculated using Dahlberg’s for-
mula [29]. The method errors of maximal airway
pressure and airflow velocity were 1.712 Pa and
0.062 m/s, respectively. On the basis of the results




After OA treatment, the mean AHI, AI, HI, and lowest
SpO2 level significantly improved from 23.1 events/h,
10.5 events/h, 12.6 events/h, and 82.1% to 10.1 events/
h, 3.3 events/h, 6.8 events/h, and 88.7%, respectively
(Table 2).
Results of CFD analysis
Before OA treatment, airflow velocities at the retro-
palatal and uvular-tip levels were faster than those at
the hard-palate level (Table 3), while negative-pressure
Figure 1. Evaluations of airway pressure and airflow velocity at each pharyngeal-airway location: (a) hard-palate level; (b) retro-
palatal level; (c) uvular-tip level; and (d) epiglottis-tip level.
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levels at the uvular- and epiglottis-tip levels were
higher than those at the hard-palate level (Table 4).
After OA treatment, airflow velocities at the retropala-
tal and epiglottis-tip levels significantly decreased from
9.0 to 5.3 m/s (p = 0.006) and 6.8 to 4.8 m/s
(p = 0.024), respectively (Table 3). Moreover, negative-
pressure levels at the retropalatal, uvular-tip, and epi-
glottis-tip levels significantly decreased from −130.3 to
−51.3 Pa, −163.1 to −76.4 Pa, and −167.2 to −77.2 Pa,
respectively (Table 4). Before OA treatment, AHI was
correlated with negative pressure at the epiglottis-tip
level (rs = −0.521; p = 0.046; Table 5). However, after
OA treatment, AHI was not correlated with negative
pressure at any of the levels (Table 6). In addition,
post-treatment change in AHI was correlated with
that in negative pressure at the uvular- (rs = −0.582;
p = 0.023) and epiglottis-tip (rs = −0.536; p = 0.040;
Table 7) levels.
Discussion
The present study investigated changes in the airway ven-
tilation conditions after OA treatment in patients with
OSA by means of CFD analysis of upper-airway models
extending from the nasal cavity to the hypopharynx.
Relationship between AHI and airway pressure in CFD
models
In a previous study that performed CFD analysis of
upper-airway ventilation conditions at inspiration in
obese children with adenoidal hypertrophy, Wootton
Table 2. Comparison of polysomnographic indices recorded
during the initial consultation and after symptom improvement





p-valueMean SD Mean SD Mean SD
AHI, events/h 23.1 12.0 10.1 6.0 −13.0 10.7 < 0.001
AI, events/h 10.5 12.0 3.3 4.0 −7.2 8.5 0.005
HI, events/h 12.6 6.7 6.8 4.1 −5.8 7.7 0.011
Lowest SpO2, %
# 82.1 7.9 88.7 4.4 6.1 5.6 0.001
SD: standard deviation; AHI: apnea–hypopnea index; AI: apnea index; HI:
hypopnea index; SpO2: oxygen saturation.
#It was not possible to measure the SpO2 level in one case.
Table 3. Post-treatment change in airflow velocity in the upper airway.
Airflow velocity, m/s
Hard-palate level Retropalatal level Uvular-tip level Epiglottis-tip level Intersite differencesa
Mean SD Mean SD Mean SD Mean SD p Post-hoc
Before 2.6 1.3 9.0 5.7 8.2 5.5 6.8 3.1 < 0.001 12, 13
After 2.1 0.9 5.3 2.9 6.6 3.2 4.8 2.0 < 0.001 12, 13, 14
Post-treatment change −0.5 1.0 −3.7 5.0** −1.6 4.4 −2.0 2.9* 0.147
SD: standard deviation. Significant difference between pre- and post-treatment levels: **p < 0.01 and *p < 0.05. aSignificant intersite differences identified by
the Friedman test with Bonferroni’s correction: 12, hard-palate level vs. retropalatal level; 13, hard-palate level vs. uvular-tip level; 14, hard-palate level vs.
epiglottis-tip level.
Table 4. Post-treatment change in upper-airway pressure.
Airway pressure, Pa
Hard-palate level Retropalatal level Uvular-tip level Epiglottis-tip level Intersite differencesa
Mean SD Mean SD Mean SD Mean SD p Post-hoc
Before −50.9 44.2 −130.3 85.8 −163.1 119.8 −167.2 113.9 <0.001 13, 14
After −27.8 21.0 −51.3 38.3 −76.4 45.4 −77.2 46.2 <0.001 13, 14
Post-treatment change 23.1 46.2 79.0 80.1** 86.7 100.8* 90.0 100.5** 0.006
SD: standard deviation. Significant difference between pre- and post-treatment levels: **p < 0.01 and *p < 0.05. aSignificant intersite differences identified by
the Friedman test with Bonferroni’s correction: 13, hard-palate level vs. uvular-tip level; 14, hard-palate level vs. epiglottis-tip level.
Table 5. Correlation between sleep data and upper-airway pressure before oral-appliance treatment.
Airway pressure (Pa)
Hard-palate level Retropalatal level Uvular-tip level Epiglottis-tip level
rs p rs p rs p rs p
AHI, events/h 0.247 0.376 −0.450 0.092 −0.496 0.060 −0.521 0.046
AI, events/h −0.127 0.652 −0.404 0.136 −0.386 0.156 −0.314 0.254
HI, events/h 0.297 0.283 −0.129 0.648 −0.132 0.639 −0.232 0.405
Lowest SpO2, %
# −0.006 0.985 0.317 0.270 0.387 0.171 0.387 0.171
AHI: apnea–hypopnea index; AI: apnea index; HI: hypopnea index; SpO2: oxygen saturation. rs: Spearman’s rank correlation coefficient.
#It was not possible to measure the SpO2 level in one case.
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et al. [18] reported that negative pressure of the phar-
yngeal airway was closely associated with the severity of
OSA. Therefore, the present study examined the rela-
tionship between airway pressure and PSG data in
patients with OSA before OA treatment and found
a correlation between pretreatment negative airway
pressure at the epiglottis-tip level and AHI.
Downing and Ku [30] reported that large negative
pressure in the pharyngeal airway at inspiration
induces pharyngeal-airway collapse. In the present
study, the pretreatment negative pressure at the epi-
glottis-tip level was large and correlated with pretreat-
ment AHI. The epiglottis-tip level is the anatomical site
that can easily induce glossoptosis. Therefore, the pre-
sent study concluded that negative pressure at the
epiglottis-tip level is correlated with pharyngeal-
airway collapse.
Additionally, it is easy to physically transform the
airway at the retropalatal and uvular-tip levels. It is,
therefore, believed that pharyngeal-airway collapse is
easily induced at these levels. In the present study,
although negative-pressure levels at the retropalatal
(rs = −0.450; p = 0.092) and uvular-tip (rs = −0.496;
p = 0.060) levels were not significantly different, they
showed a weak correlation with AHI; they showed the
same tendency at the epiglottis-tip level. It is possible
that these results might have been influenced by the
small sample size. Nevertheless, these results suggest
that CFD analysis of negative-airway pressure at
inspiration is an effective method for evaluating the
severity of OSA, which the authors believe to be
a novel finding because it cannot be obtained solely
by morphological observation.
Airflow velocity in CFD models
In a previous study, Downing and Ku [30] reported that
airflow velocities obtained from CFD models are affected
by the size and shape of the airway and that a narrowed
airway is subject to higher airflow velocities than an unob-
structed one. In other words, in a CFDmodel, the site with
the higher airflow velocity indicates the region of ventila-
tory impairment. In the present study, airflow velocities at
the retropalatal and uvular-tip levels in OSA patients
before OA treatment were faster than those at the hard-
palate level. The authors believe that, in these patients,
airways at the retropalatal and uvular-tip levels were nar-
row, which caused ventilatory impairment. In many stu-
dies, endoscopy findings have revealed that patients with
OSA exhibit obstruction in the velopharynx [31,32]. The
retropalatal and uvular-tip levels defined in the present
study correspond to the velopharynx, and the results
observed in this study are similar to those reported in
previous studies. These findings indicate that airflow velo-
cities determined by CFD analysis might be effective for
detecting sites of ventilatory impairment in the airway.
CFD findings after OA treatment
The present study evaluated the changes in upper-
airway ventilation conditions after OA treatment by
performing CFD analysis. After OA treatment, airflow
Table 6. Correlation between sleep data and upper-airway pressure after oral-appliance treatment.
Airway pressure (Pa)
Hard-palate level Retropalatal level Uvular-tip level Epiglottis-tip level
rs p rs p rs p rs p
AHI, events/h 0.388 0.153 0.300 0.277 0.141 0.616 0.159 0.571
AI, events/h 0.013 0.965 0.021 0.940 −0.361 0.186 −0.393 0.147
HI, events/h 0.351 0.200 0.295 0.286 0.370 0.174 0.410 0.129
Lowest SpO2, %
# −0.122 0.664 0.239 0.391 0.215 0.442 0.233 0.404
AHI: apnea–hypopnea index; AI: apnea index; HI: hypopnea index; SpO2: oxygen saturation. rs: Spearman’s rank correlation coefficient.
#It was not possible to measure the SpO2 level in one case.
Table 7. Correlation between sleep data and upper-airway pressure with relation to treatment change.
Airway pressure (Pa)
Hard-palate level Retropalatal level Uvular-tip level Epiglottis-tip level
rs p rs p rs p rs p
AHI, events/h 0.168 0.550 −0.475 0.073 −0.582 0.023 −0.536 0.040
AI, events/h 0.016 0.955 −0.239 0.391 −0.274 0.324 −0.145 0.607
HI, events/h 0.221 0.428 −0.442 0.100 −0.386 0.156 −0.507 0.054
Lowest SpO2, %
# −0.038 0.898 0.030 0.919 0.193 0.510 0.075 0.798
AHI: apnea–hypopnea index; AI: apnea index; HI: hypopnea index; SpO2: oxygen saturation. rs: Spearman’s rank correlation coefficient.
#It was not possible to measure the SpO2 level in one case.
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velocities at the retropalatal and epiglottis-tip levels, as
well as negative-pressure levels at the retropalatal, uvu-
lar-tip, and epiglottis-tip levels, decreased significantly
relative to pretreatment levels.
Chan et al. [33] evaluated morphological changes of
the pharyngeal airway after OA treatment on the basis
of magnetic resonance imaging findings and found that
the volume of the velopharynx and hypopharynx had
increased after treatment. Additionally, the present
findings indicated that OA treatment might help
enlarge the pharyngeal airway at the retropalatal and
epiglottis-tip levels, leading to improvement of ventila-
tion conditions in the pharyngeal airway.
Changes in CFD and PSG data after OA treatment
In the present study, the post-treatment change in AHI
was correlated with that in negative pressure at the
uvular- and epiglottis-tip levels. This suggests that it
is important to improve the negative-pressure levels at
the uvular- and epiglottis-tip levels to achieve
a decrease in AHI. In an endoscopy study, Sasao et al.
[12] evaluated morphological changes in the pharyn-
geal airway when the lower jaw was moved forward.
The authors found that the velopharynx enlarges with
OA treatment, which easily allows improvement
of AHI.
Expansion of the velopharynx, leading to ventilatory
impairment, has an influence on downstream airflow.
It is possible that, in the present study, the velopharynx
was enlarged because of OA treatment, leading to
improvement in ventilatory impairment. This, in turn,
might have helped relieve the negative pressure at the
uvular- and epiglottis-tip levels, causing a decrease
in AHI.
Validity of CFD models
In a study by Zhao et al. [34], pharyngeal-airway pres-
sure before OA treatment in patients with OSA was
approximately −50 Pa, which is lower than the pressure
level observed in the present study. However, the flow
rate reported in the previous study was one-third of the
value observed in the present study. Therefore, the
authors believe that the present results show a similar
tendency as those reported by Zhao et al. and that the
CFD methodology is accurate in the present study.
Case presentation
Although there have been several reports on the elig-
ibility criteria for OA treatment and the effect of OAs
on OSA [8,9,12,35], there are few reports on the reason
for failure of OA treatment in some instances. This
section depicts the results of CFD analysis of patients
who were responsive or nonresponsive to OA
treatment.
One of the responsive patients exhibited severe OSA
and a pretreatment AHI of 50.3 events/h. However, after
OA treatment, the AHI had decreased to 15.7 events/h,
which indicated a 68.8% improvement (Figure 2). The
results of CFD analysis revealed that OA treatment had
led to improvement of airflow velocity and negative pres-
sure from the retropalatal level to the epiglottis-tip level.
Although this patient did not meet the AASM eligibility
criteria for OSA severity [8], the authors believe that
improvement of ventilatory impairment with OA treat-
ment led to a decrease in AHI in this case.
In a representative nonresponsive case, in which the
AHI did not improve upon OA treatment, a patient
exhibited a pretreatment AHI of 20.1 events/h and
moderate OSA in accordance with the AASM guide-
lines; this was a case in which OA treatment was
indicated [8]. The pretreatment airflow velocity and
negative pressure at the epiglottis-tip level were high.
After treatment, the AHI in this case had increased to
29.0 events/h (Figure 3a,b), and negative-pressure
levels had increased in the entire upper airway. In the
present study, these findings were confirmed by ana-
lyzing a sagittal section of the left side of the nose
(Figure 3c), which revealed a site in the nasal airway
that exhibited relatively high airflow velocity; the nega-
tive-pressure level downstream from the site was also
high. In this case, although OA treatment helped
improve the airflow velocity at the epiglottis-tip level,
the AHI was thought to have increased because of
a problem in the nose that had occurred during
treatment.
The findings of these two cases suggest that CFD
analysis of not only the pharyngeal airway but also the
upper airway (including the nasal airway) is effective
for detecting sites of ventilatory impairment and might
contribute to improvement of treatment outcomes
in OSA.
Limitations
The upper-airway model constructed in this study used
data generated in the wake state (not the sleep state);
therefore, it did not include an adjustment for transfor-
mation during breathing. However, pharyngeal-airway
pressure at inspiration and in deep stages of sleep with
complete muscle atonia and airway collapse influence
airway transformation during sleep. However, the
authors believe that the results obtained by analysis of
data generated in an awakened state may be useful
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because the present data revealed a correlation between
pharyngeal airway pressure and sleep parameters.
With regard to OA treatment, because of differences
in the clinical states of individuals, the present study
did not administer a uniform type of OA or achieve
a uniform change in mandibular position. This was
a preliminary study, and the authors intend to perform
detailed and individual analyses in a larger sample in
the future.
Furthermore, a randomized sampling approach was
not used, which may have introduced a bias based on
the available patients; this should be considered when
Figure 2. A case of severe OSA in which the symptoms improved after OA treatment. (a) Before treatment – The AHI was
50.3 events/h. Left: The airflow velocity was extremely high from the retropalatal level to the epiglottis-tip level, which revealed the
causative site of the severe OSA (large red arrows). Right: The negative pressure at the lower part of the retropalatal level was
extremely high, causing strong contraction of the lower part of the retropalatal level (large red arrows). (b) After treatment – The
AHI had improved to 15.7 events/h. Left: The airflow velocity from the retropalatal level to the epiglottis-tip level had decreased
after OA treatment (small yellow arrow). Right: The negative pressure at the lower part of the retropalatal level had decreased after
OA treatment (small yellow arrows). OSA: obstructive sleep apnea; OA: oral appliance; AHI: apnea–hypopnea index.
Figure 3. A case of mild-to-moderate OSA in which the symptoms did not improve with OA treatment. (a) Before treatment – The
AHI was 20.1 events/h. Left: The airflow velocity was extremely high at the epiglottis-tip level (large red arrow). Right: The negative
pressure was extremely high at the epiglottis-tip level (large red arrow). (b) After treatment – The AHI had worsened to 29.0 events/
h. Left: The airflow velocity at the epiglottis-tip level had decreased after OA treatment (small yellow arrow). Right: However, the
negative pharyngeal-airway pressure had become even more severe (large red arrow). (c) After treatment – Left: Frontal view of the
upper airway; the red line cuts off the left part of the nose. Right: Sagittal view of a plane on the left side of the nose. The airflow
velocity at the nose was extremely high, which indicated the site of ventilatory impairment (large red arrow). In this case, OSA was
thought to be caused by nasal-airway obstruction. OSA: obstructive sleep apnea; OA: oral appliance; AHI: apnea–hypopnea index.
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interpreting the findings of this study. A future study
should include a randomized approach, in order to
reduce the risk of bias during patient sampling.
Conclusion
The present study examined the changes in upper-airway
ventilation conditions after OA treatment using CFD.
The results demonstrated that OA treatment improved
the ventilation conditions of the pharyngeal airway and
significantly improved the AHI. Additionally, airway
pressure and airflow velocity data obtained from CFD
models demonstrated the severity of OSA and the site of
ventilatory impairment in OSA, respectively.
Conflicts of interest
The authors have no potential conflicts of interest to declare.
Funding
This work was supported by Grants-in-Aid for Scientific
Research (KAKENHI) from the Japan Society for the
Promotion of Science (JSPS) (15K20605, 16K15841,
17K11965, and 18K09859)
References
[1] He J, Kryger MH, Zorick FJ, et al. Mortality and apnea
index in obstructive sleep apnea. Experience in 385 male
patients. Chest. 1988;94(1):9–14.
[2] Campos-Rodriguez F, Peña-Griñan N, Reyes-Nuñez N,
et al. Mortality in obstructive sleep apnea-hypopnea
patients treated with positive air way pressure. Chest.
2005;128(2):624–633.
[3] Marin JM, Carrizo SJ, Vicente E, et al. Long-term car-
diovascular outcomes in men with obstructive sleep
apnoea-hypopnoea with or without treatment with con-
tinuous positive airway pressure: an observational study.
Lancet. 2005;365(9464):1046–1053.
[4] Clark GT, Blumenfeld I, Yoffe N, et al. A crossover
study comparing the efficacy of continuous positive air-
way pressure with anterior mandibular positioning
devices on patients with obstructive sleep apnea.
Chest. 1996;109(6):1477–1483.
[5] Ferguson KA, Ono T, Lowe AA, et al. A randomized cross-
over study of an oral appliance vs nasal-continuous positive
airway pressure in the treatment of mild-moderate obstruc-
tive sleep apnea. Chest. 1996;109(5):1269–1275.
[6] Engleman HM, McDonald JP, Graham D, et al.
Randomized crossover trial of two treatments for sleep
apnea hypopnea syndrome. Am J Respir Crit Care Med.
2002;166(6):855–859.
[7] Sawyer AM, Gooneratne NS, Marcus CL, et al.
A systematic review of CPAP adherence across age
groups: clinical and empiric insights for developing
CPAP adherence interventions. Sleep Med Rev.
2011;15(6):343–356.
[8] Kushida CA, Morgenthaler TI, Littner MR, et al.
Practice parameters for the treatment of snoring and
obstructive sleep apnea with oral appliances: an update
for 2005. Sleep. 2006;29(2):240–243.
[9] Johal A, Battagel JM, Kotecha BT. Sleep nasendoscopy:
a diagnostic tool for predicting treatment success with
mandibular advancement splints in obstructive sleep
apnoea. Eur J Orthod. 2005;27(6):607–614.
[10] Doff MH, Hoekema A, Pruim GJ, et al. Effects of
a mandibular advancement device on the upper airway
morphology: a cephalometric analysis. J Oral Rehabil.
2009;36(5):330–337.
[11] Kaur A, Chand P, Singh RD, et al. Computed tomographic
evaluation of the effects ofmandibular advancement devices
on pharyngeal dimension changes in patients with obstruc-
tive sleep apnea. Int J Prosthodont. 2012;25(5):497–505.
[12] Sasao Y, Nohara K, Okuno K, et al. Videoendoscopic
diagnosis for predicting the response to oral appliance
therapy in severe obstructive sleep apnea. Sleep Breath.
2014;18(4):809–815.
[13] Xu C, Sin S, McDonough JM, et al. Computational fluid
dynamics modeling of the upper airway of children with
obstructive sleep apnea syndrome in steady flow.
J Biomech. 2006;39(11):2043–2054.
[14] Mihaescu M, Mylavarapu G, Gutmark EJ, et al. Large eddy
simulation of the pharyngeal airflow associated with
obstructive sleep apnea syndrome at pre and post-surgical
treatment. J Biomech. 2011;44(12):2221–2228.
[15] Iwasaki T, Takemoto Y, Inada E, et al. The effect of
rapid maxillary expansion on pharyngeal airway pres-
sure during inspiration evaluated using computational
fluid dynamics. Int J Pediatr Otorhinolaryngol. 2014;78
(8):1258–1264.
[16] Iwasaki T, Sato H, Suga H, et al. Herbst appliance effects on
pharyngeal airway ventilation evaluated using computa-
tional fluid dynamics. Angle Orthod. 2017;87(3):397–403.
[17] De Backer JW, Vanderveken OM, Vos WG, et al.
Functional imaging using computational fluid dynamics
to predict treatment success of mandibular advance-
ment devices in sleep-disordered breathing. J Biomech.
2007;40(16):3708–3714.
[18] Wootton DM, Luo H, Persak SC, et al. Computational
fluid dynamics endpoints to characterize obstructive
sleep apnea syndrome in children. J Appl Physiol.
2014;116(1):104–112.
[19] WuMJ, Ho CY, Tsai HH, et al. Retropalatal Müller grade is
associated with the severity of obstructive sleep apnea in
non-obese Asian patients. Retropalatal Müller grade and
OSA in non-obese. Sleep Breath. 2011;15(4):799–807.
[20] Nakano H, Mishima K, Matsushita A, et al. Efficacy of
the Silensor for treating obstructive sleep apnea
syndrome. Oral Maxillofac Surg. 2013;17(2):105–108.
[21] Suga H, Mishima K, Nakano H, et al. Different therapeutic
mechanisms of rigid and semi-rigid mandibular reposition-
ing devices in obstructive sleep apnea syndrome.
J Craniomaxillofac Surg. 2014;42(8):1650–1654.
[22] Sutherland K, Chan ASL, Ngiam J, et al. Qualitative
assessment of awake nasopharyngoscopy for prediction
of oral appliance treatment response in obstructive sleep
apnoea. Sleep Breath. 2018;22(4):1029–1036.
[23] Rose EC, Schnegelsberg C, Staats R, et al. Occlusal side
effects caused by a mandibular advancement appliance
216 H. SUGA ET AL.
in patients with obstructive sleep apnea. Angle Orthod.
2001;71(6):452–460.
[24] Doff MH, Veldhuis SK, Hoekema A, et al. Long-term
oral appliance therapy in obstructive sleep apnea syn-
drome: a controlled study on temporomandibular side
effects. Clin Oral Investig. 2012;16(3):689–697.
[25] Okuno K, Sasao Y, Nohara K, et al. Endoscopy evalua-
tion to predict oral appliance outcomes in obstructive
sleep apnoea. Eur Respir J. 2016;47(5):1410–1419.
[26] Isacsson G, Nohlert E, Fransson AMC, et al. Use of bibloc
and monobloc oral appliances in obstructive sleep apnoea:
a multicentre, randomized, blinded, parallel-group equiva-
lence trial. Eur J Orthod. 2018. doi: 10.1093/ejo/cjy030.
[27] Iwasaki T, Saitoh I, Takemoto Y, et al. Evaluation of
upper airway obstruction in Class II children with
fluid-mechanical simulation. Am J Orthod Dentofacial
Orthop. 2011;139(2):e135–145.
[28] Mukaihara K, Hasegawa-Moriyama M, Iwasaki T, et al.
Evaluation of the pharyngeal airway using computa-
tional fluid dynamics in patients with acromegaly.
Laryngoscope Investig Otolaryngol. 2018;3(2):133–138.
[29] Dahlberg G. Statistical methods for medical and biological
students. London: George Allen and Unwin, Ltd.; 1940.
[30] Downing JM, Ku DN. Effects of frictional losses and
pulsatile flow on the collapse of stenotic arteries.
J Biomech Eng. 1997;119(3):317–324.
[31] Ravesloot MJ, de Vries N. One hundred consecutive
patients undergoing drug-induced sleep endoscopy:
results and evaluation. Laryngoscope. 2011;121
(12):2710–2716.
[32] De Corso E, Bastanza G, Della Marca G, et al. Drug-
induced sleep endoscopy as a selection tool for mandib-
ular advancement therapy by oral device in patients
with mild to moderate obstructive sleep apnoea. Acta
Otorhinolaryngol Ital. 2015;35(6):426–432.
[33] Chan AS, Sutherland K, Schwab RJ, et al. The effect of
mandibular advancement on upper airway structure in
obstructive sleep apnoea. Thorax. 2010;65(8):726–732.
[34] Zhao M, Barber T, Cistulli P, et al. Computational fluid
dynamics for the assessment of upper airway response
to oral appliance treatment in obstructive sleep apnea.
J Biomech. 2013;46(1):142–150.
[35] Gjerde K, Lehmann S, Berge ME, et al. Oral appliance
treatment in moderate and severe obstructive sleep
apnoea patients non-adherent to CPAP. J Oral
Rehabil. 2016;43(4):249–258.
CRANIO®: THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE 217
